Skip to content
Review Open access

Swine Group A rotavirus vaccines: current status, adjuvant strategies, challenges, and future perspectives

Jul 2026 · Frontiers in Veterinary Science · Vol 13 · 0 citations · 210 references
Medicine

TL;DR

This review analyzes the potential contribution of adjuvant strategies to developing a universal porcine rotavirus vaccine capable of broad, long-lasting cross-protection and identifies key unresolved scientific questions and critical knowledge gaps in the field with the aim of guiding future research priorities.

Abstract

Swine Group A rotavirus is one of the primary intestinal pathogens causing severe diarrhea in newborn piglets, with high incidence and mortality resulting in substantial economic losses to the global swine industry. Vaccination, alongside rigorous biosecurity measures, remains the core strategy for controlling porcine Group A rotavirus infection; however, continuous genetic variation via genomic reassortment, point mutations, and diverse G/P genotype combinations drives the constant emergence of new circulating strains that may evade immune protection from existing vaccines. These genetic changes may also give rise to highly pathogenic variants, increasing large-scale outbreak risk. Therefore, developing vaccines that provide stable, broad cross-protection against viral strain diversity is particularly critical. Vaccine adjuvants play a vital role in enhancing and modulating immune responses, broadening protection spectra, and reducing the antigen dose required for protection especially valuable when facing rapidly changing genotypes or limited vaccine antigen supplies. In recent years, advances in adjuvant design and formulation strategies have clearly improved the immunogenicity and duration of protection of swine Group A rotavirus vaccines, as evidenced by significantly reduced diarrhea incidence and viral shedding intensity in vaccinated piglets. Building on an overview of the current status, advantages, and challenges of different porcine Group A rotavirus vaccine types, this review focuses on the mechanisms of action, application advantages, existing limitations, and methodological strategies of adjuvants. It further analyzes the potential contribution of adjuvant strategies to developing a universal porcine rotavirus vaccine capable of broad, long-lasting cross-protection. Finally, this review identifies key unresolved scientific questions and critical knowledge gaps in the field, with the aim of guiding future research priorities.

Read PDF

Similar papers

Review Open access Jan 2026

Live Attenuated Vaccines for African Swine Fever: Perspectives on Their Use and Strategic Directions

African swine fever (ASF) continues to cause substantial economic and production losses in affected countries. Although biosecurity and conventional control measures remain essential, the challenges of ASF control underscore the need for safe and effective vaccines as additional tools, particularly in endemic settings....

Diep Van Nguyen, D. Pham · 0 citations
Review Open access Sep 2026

Current challenges emerging strategies and future directions in vaccine development for haemorrhagic septicemia

Haemorrhagic septicemia (HS), caused by Pasteurella multocida serotypes B:2 and E:2, remains a major infectious disease of cattle and buffalo in endemic regions of Asia and Africa and has increasingly been recognized as a threat to susceptible wildlife. Despite decades of vaccination, recurrent outbreaks continue, high...

R. Raj, Ashwani Kumar Sharma · 0 citations
Review Open access Aug 2026

Porcine Rotavirus: pathogenic mechanisms, host immune responses, and progress toward control

Porcine Rotavirus (PoRV), a major pathogen causing diarrhea in piglets and significant economic losses, exhibits high genotypic diversity and poses a risk of cross-species transmission. PoRV infection is initiated by the interaction of its outer capsid proteins, VP4 and VP7, with multiple host cell receptors (e.g., sia...

Jiyu Liu, Yuexin Dong, Zhongxing Xu et al. · 0 citations
Review Open access Oct 2026

Phage-Based Vaccine Platforms for Typhoid Fever: A Transformative Approach to Global Health and Antimicrobial Resistance

Typhoid fever, caused by Salmonella enterica serovars Typhi and Paratyphi, remains a major public health threat across Africa and Asia and causes substantial annual morbidity. Transmission persists in low- and middle-income countries (LMICs), where access to safe water and sanitation is limited. While improvements in w...

Tambe David Tipah, N. E. Nnadi, R. Slavcev · 0 citations
Review Open access Aug 2026

A Review on Escherichia coli Vaccine Development: Current Progress and Future Prospects

Escherichia coli ( E. coli ) is a diverse bacterium commonly found in the intestinal tract of humans and animals. While many strains are harmless, pathogenic variants such as enterotoxigenic (ETEC), enterohemorrhagic (EHEC), and avian pathogenic (APEC) strains cause significant health problems in humans and livesto...

Tayyaba Fatima · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.